Retatrutide: The Triple-Agonist Powerhouse Redefining Metabolic Research
What Retatrutide Is and Why Triple-Agonism Matters Retatrutide is a next-generation, unimolecular metabolic agent that simultaneously activates three key receptors: the glucose-dependent insulinotropic polypeptide receptor (GIPR), the glucagon-like peptide-1 receptor (GLP-1R), and the glucagon receptor (GCGR). This triple-agonist profile reflects an intentional design strategy to harness overlapping yet distinct metabolicContinue Reading